Prospeo
Hero Section BackgroundHero Section Background
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)

Biotechnology ResearchFlag of CAToronto, Ontario, Canada1-10 Employees

Company overview

Headquarters27 St. Clair Ave East, PO Box 305, Toronto, ON M4T 2M5, CA
Phone number+16474287031
Website
SIC873
Keywords
Sepsis, Novel Therapeutics, Treating Acute Kidney Injury, Acute Organ Inflammation, Treatments For Inflammation
Founded2010
Employees1-10
Socials

Key Contact at Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)

Flag of CA

Aaron Benson

Director Of Communications

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) Email Formats

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) uses 2 email formats. The most common is {2char} (e.g., {2char}@archbiopartners.com), used 66.7% of the time.

FormatExamplePercentage
{2char}
{2char}@archbiopartners.com
66.7%
{first initial}{last name}
jdoe@archbiopartners.com
33.3%

About Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The Company is developing a platform of novel drugs targeting the dipeptidase-1 (DPEP1) inflammation pathway prevalent in the kidneys, lungs, and liver. LSALT peptide and cilastatin are lead drug candidates in separate Phase II trials targeting acute kidney injury caused by inflammation and toxins, respectively. Both indications represent significant unmet medical needs in global kidney care. For more science details: www.archbiopartners.com/our-science For investor materials and filings: www.archbiopartners.com/investor-hub

$

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) revenue & valuation

Annual revenue$37,641
Revenue per employee$6,000
Estimated valuation?$120,451
Total funding$5,002,400

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Manager
Director
Entry

Employees by Department

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-04-239$4,000,000
2024-08-2914$433,300
2024-11-1514$326,500
2025-04-0514$242,600

Funding Insights

$5,002,400

Total funding amount

$242,600

Most recent funding amount

4

Number of funding rounds

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) Tech Stack

Discover the technologies and tools that power Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

reCAPTCHA

Security

Slick

Slick

JavaScript libraries

Site Kit

Site Kit

Analytics

Highcharts

Highcharts

JavaScript graphics

GenerateBlocks

GenerateBlocks

Page builders

jQuery UI

jQuery UI

JavaScript libraries

Animate.css

Animate.css

UI frameworks

jQuery Migrate

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

OpenSSL

OpenSSL

Web server extensions

Frequently asked questions

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) is located in Toronto, Ontario, CA.
You can reach Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) at +16474287031.
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) has raised a total of $5,002,400 across 4 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles